Search - tctmd.com

Displaying 501 - 520 of 648

Sort: Relevancy | Date

Presentation TCT 2013

The BioMime Stent and Merit Clinical Trials

Presenter: Martin Leon

October 27, 2013

Presentation TCT 2013

Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A

Presenter: Martin Leon

October 27, 2013

Presentation TCT 2013

PARTNER A (Surgery vs. TAVR at 2 Years): Essential Results

Presenter: Martin Leon

October 27, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Daily News

高风险亚组从瑞舒伐他汀中获得肾脏保护

Caitlin E. Cox

October 11, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

Presentation SOLACI 2013

Why Do I Prefer Balloon Expandable Devices for TAVI?

Presenter: Martin B. Leon

July 25, 2013

Presentation SOLACI 2013

The Unmet Needs in TAVR: Preventing Stroke, Paravalvular Leak and Beyond!

Presenter: Martin B. Leon

July 24, 2013

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Daily News

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Caitlin E. Cox

July 11, 2013

Presentation Transradial 2013

Introduction: Current Perspectives on Transradial Access

Presenter: Martin B. Leon

June 28, 2013

News Daily News

TAVR相关的主动脉根断裂具有危险性但可预测

Caitlin E. Cox

June 28, 2013

News Daily News

TAVR-Associated Aortic Root Rupture Hazardous but Predictable

Caitlin E. Cox

June 28, 2013

News Daily News

La Rotura de la Raíz Aórtica secundaria a la TAVR es Peligrosa pero Predecible

Caitlin E. Cox

June 28, 2013

Presentation TVT 2013

Updates from PARTNER 2A

Presenter: Martin Leon

June 13, 2013

Presentation TVT 2013

The Valve Medical TAVR System (Israel)

Presenter: Martin Leon

June 13, 2013

Presentation TVT 2013

A Review of New Balloon Aortic Valvuloplasty Systems: InterValve Loma Vista, Cardiosculpt, and PiR2

Presenter: Martin Leon

June 12, 2013

Advertisement

The BioMime Stent and Merit Clinical Trials

Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A

PARTNER A (Surgery vs. TAVR at 2 Years): Essential Results

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

高风险亚组从瑞舒伐他汀中获得肾脏保护

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Why Do I Prefer Balloon Expandable Devices for TAVI?

The Unmet Needs in TAVR: Preventing Stroke, Paravalvular Leak and Beyond!

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Introduction: Current Perspectives on Transradial Access

TAVR相关的主动脉根断裂具有危险性但可预测

TAVR-Associated Aortic Root Rupture Hazardous but Predictable

La Rotura de la Raíz Aórtica secundaria a la TAVR es Peligrosa pero Predecible

Updates from PARTNER 2A

The Valve Medical TAVR System (Israel)

A Review of New Balloon Aortic Valvuloplasty Systems: InterValve Loma Vista, Cardiosculpt, and PiR2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content